Is Phenibut Legal in Kansas? (2026)

Instrument

Unlawful abuse of toxic vapors

Source

https://kslegislature.gov/li/b2025_26/statute/021_000_0000_chapter/021_057_0000_article/021_057_0012_section/021_057_0012_k/

Retrieved

2026-10-31

Fingerprint

f017d02cb7118eeb

21-5712.
 Unlawful abuse of toxic vapors.
 (a) Unlawful abuse of toxic vapors is possessing, buying, using, smelling or inhaling toxic vapors with the intent of causing a condition of euphoria, excitement, exhilaration, stupefaction or dulled senses of the nervous system.
(b) Unlawful abuse of toxic vapors is a class B nonperson misdemeanor.
(c) In addition to any sentence or fine imposed, the court shall enter an order which requires that the person enroll in and successfully complete an alcohol and drug safety action education program, treatment program or both such programs as provided in K.S.A. 8-1008, and amendments thereto.
(d) This section shall not apply to the inhalation of anesthesia or other substances for medical or dental purposes.
(e) For the purposes of this section, the term “toxic vapors” means vapors from the following substances or products containing such substances:
(1) Alcohols, including methyl, isopropyl, propyl or butyl;
(2) aliphatic acetates, including ethyl, methyl, propyl or methyl cellosolve acetate;
(3) acetone;
(4) benzene;
(5) carbon tetrachloride;
(6) cyclohexane;
(7) freons, including freon 11, freon 12 and other halogenated hydrocarbons;
(8) hexane;
(9) methyl ethyl ketone;
(10) methyl isobutyl ketone;
(11) naptha;
(12) perchlorethylene;
(13) toluene;
(14) trichloroethane; or
(15) xylene.
(f) In a prosecution for a violation of this section, evidence that a container lists one or more of the substances described in subsection (e) as one of its ingredients shall be prima facie evidence that the substance in such container contains toxic vapors.
History: 
L. 2009, ch. 32, § 12; L. 2015, ch. 20, § 1; July 1.

Instrument

Schedule I, hallucinogenic substances

Source

https://www.kslegislature.gov/li/b2025_26/statute/065_000_0000_chapter/065_041_0000_article/065_041_0005_section/065_041_0005_k/

Retrieved

2026-11-06

Fingerprint

ff1107b180540546

(d) Any material, compound, mixture or preparation that contains any quantity of the following hallucinogenic substances, their salts, isomers and salts of isomers, unless specifically excepted, whenever the existence of these salts, isomers and salts of isomers is possible within the specific chemical designation:
(1)  Alpha-ethyltryptamine   7249Some trade or other names: etryptamine; Monase; α-ethyl-1H-indole-3-ethanamine; 3-(2-aminobutyl) indole; α-ET; and AET.
(2)  4-bromo-2,5-dimethoxy-amphetamine  7391Some trade or other names: 4-bromo-2,5-dimethoxy-alpha-methylphenethylamine; 4-bromo-2,5-DMA.
(3)  2,5-dimethoxyamphetamine  7396Some trade or other names: 2,5-dimethoxy-alpha-methyl-phenethylamine; 2,5-DMA.
(4)  4-methoxyamphetamine  7411Some trade or other names: 4-methoxy-alpha-methylphene-thylamine; paramethoxyamphetamine; PMA.
(5)  5-methoxy-3,4-methylenedioxy-amphetamine  7401
(6)  4-methyl-2,5-dimethoxy-amphetamine  7395Some trade or other names: 4-methyl-2,5-dimethoxy-alpha-methylphenethylamine; “DOM”; and “STP”.
(7)  3,4-methylenedioxy amphetamine  7400
(8)  3,4-methylenedioxymethamphetamine (MDMA)  7405
(9)  3,4-methylenedioxy-N-ethylamphetamine (also known as N-ethyl-alpha-methyl-3,4 (methylenedioxy) phenethylamine, N-ethyl MDA, MDE, and MDEA)  7404
(10)  N-hydroxy-3,4-methylenedioxyamphetamine (also known as N-hydroxy-alpha-methyl-3,4-(methylenedioxy) phenethylamine, and N-hydroxy MDA)  7402
(11)  3,4,5-trimethoxy amphetamine  7390
(12)  Bufotenine  7433Some trade or other names: 3-(Beta-Dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol; N, N-dimethylserotonin; 5-hydroxy-N,N-dimethyltryptamine; mappine.
(13)  Diethyltryptamine  7434Some trade or other names: N,N-Diethyltryptamine; DET.
(14)  Dimethyltryptamine  7435Some trade or other names: DMT.
(15)  Ibogaine  7260Some trade or other names: 7-Ethyl-6,6 Beta,7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-5H-pyrido[1',2':1,2]azepino[5,4-b]indole; Tabernanthe iboga
(16)  Lysergic acid diethylamide  7315
(17)  Marijuana  7360
(18)  Mescaline  7381
(19)  Parahexyl  7374Some trade or other names: 3-Hexyl-l-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran; Synhexyl.
(20)  Peyote  7415Meaning all parts of the plant presently classified botanically as Lophophora williamsii Lemaire, whether growing or not, the seeds thereof, any extract from any part of such plant, and every compound, manufacture, salts, derivative, mixture or preparation of such plant, its seeds or extracts.
(21)  N-ethyl-3-piperidyl benzilate  7482
(22)  N-methyl-3-piperidyl benzilate  7484
(23)  Psilocybin  7437
(24)  Psilocyn  7438Some trade or other names: Psilocin.
(25)  Ethylamine analog of phencyclidine  7455Some trade or other names: N-ethyl-1-phenyl-cyclo-hexylamine; (1-phenylcyclohexyl)ethylamine; N-(1-phenylcyclohexyl)ethylamine; cyclohexamine; PCE.
(26)  Pyrrolidine analog of phencyclidine  7458Some trade or other names: 1-(1-phenylcyclohexyl)-pyrrolidine; PCPy; PHP.
(27)  Thiophene analog of phencyclidine  7470Some trade or other names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine; 2-thienyl analog of phencyclidine; TPCP; TCP.
(28)  1-[1-(2-thienyl)-cyclohexyl] pyrrolidine  7473Some other names: TCPy.
(29)  2,5-dimethoxy-4-ethylamphetamine  7399Some trade or other names: DOET.
(30)  Salvia divinorum or salvinorum A; all parts of the plant presently classified botanically as salvia divinorum, whether growing or not, the seeds thereof, any extract from any part of such plant, and every compound, manufacture, salts, derivative, mixture or preparation of such plant, its seeds or extracts.
(31)  Datura stramonium, commonly known as gypsum weed or jimson weed; all parts of the plant presently classified botanically as datura stramonium, whether growing or not, the seeds thereof, any extract from any part of such plant, and every compound, manufacture, salts, derivative, mixture or preparation of such plant, its seeds or extracts.
(32)  1-(3-[trifluoromethylphenyl])piperazineSome trade or other names: TFMPP.
(33)  4-Bromo-2,5-dimethoxyphenethylamine  7392
(34)  2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7), its optical isomers, salts and salts of optical isomers  7348
(35)  Alpha-methyltryptamine (other name: AMT)  7432
(36)  5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT), its isomers, salts and salts of isomers  7439
(37)  2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E)  7509
(38)  2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D)  7508
(39)  2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C)  7519
(40)  2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I)  7518
(41)  2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2)  7385
(42)  2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-4)  7532
(43)  2-(2,5-Dimethoxyphenyl)ethanamine (2C-H)  7517
(44)  2-(2,5-Dimethoxy-4-nitrophenyl)ethanamine (2C-N)  7521
(45)  2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P)  7524
(46)  5–methoxy–N,N–dimethyltryptamine (5–MeO–DMT)  7431Some trade or other names: 5–methoxy–3–[2–(dimethylamino) ethyl]indole.
(47)  2–(4–iodo–2,5–dimethoxyphenyl)–N–(2–methoxybenzyl)ethanamine  7538Some trade or other names: 25I–NBOMe; 2C–I–NBOMe; 25I; Cimbi–5.
(48)  2–(4–chloro–2,5–dimethoxyphenyl)–N–(2–methoxybenzyl)ethanamine  7537Some trade or other names: 25C–NBOMe; 2C–C–NBOMe; 25C; Cimbi–82.
(49)  2–(4–bromo–2,5–dimethoxyphenyl)–N–(2–methoxybenzyl)ethanamine  7536Some trade or other names: 25B–NBOMe; 2C–B–NBOMe; 25B; Cimbi–36.
(50)  2-(2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamineSome trade or other names: 25H-NBOMe.
(51)  2-(2,5-dimethoxy-4-methylphenyl)-N-(2-methoxybenzyl)ethanamineSome trade or other names: 25D-NBOMe; 2C-D-NBOMe.
(52)  2-(2,5-dimethoxy-4-nitrophenyl)-N-(2-methoxybenzyl)ethanamineSome trade or other names: 25N-NBOMe, 2C-N-NBOMe.
(53)  1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1 H-pyrrolo[2,3-b]pyridine-3-carboxamide (5F-CUMYL-P7AICA)  7085
(54)  2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one (other names: methoxetamine, MXE)  7286
(55)  1-(4-methoxyphenyl)-N-methylpropan-2-amine (other names: para-methoxymethamphetamine, PMMA)   1245

Instrument

Schedule I controlled substances

Source

https://www.kslegislature.gov/b2025_26/laws/065_000_0000_chapter/065_041_0000_article/065_041_0005_section/065_041_0005_k/

Retrieved

2026-11-01

Fingerprint

dae4cdee5e918a86

(g) Any material, compound, mixture or preparation that contains any quantity of the following substances: (1)  N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl), its optical isomers, salts and salts of isomers (2)  N-[1-(2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl), its optical isomers, salts and salts of isomers (3)  Tianeptine, its optical isomers, salts and salts of isomers

Instrument

Schedule III: depressants

Source

https://www.kslegislature.gov/li/b2025_26/statute/065_000_0000_chapter/065_041_0000_article/065_041_0009_section/065_041_0009_k/

Retrieved

2026-10-31

Fingerprint

afd306455fe256ac

(b) Unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a potential for abuse associated with a depressant effect on the central nervous system:
(1)  Any compound, mixture or preparation containing:
(A)  Amobarbital  2126
(B)  Secobarbital  2316
(C)  Pentobarbital  2271or any salt thereof and one or more other active medicinal ingredients which are not listed in any schedule.
(2)  Any suppository dosage form containing:
(A)  Amobarbital  2126
(B)  Secobarbital  2316
(C)  Pentobarbital  2271or any salt of any of these drugs and approved by the Food and Drug Administration for marketing only as a suppository.
(3)  Any substance which contains any quantity of a derivative of barbituric acid, or any salt of a derivative of barbituric acid, except those substances which are specifically listed in other schedules  2100
(4)  Chlorhexadol  2510
(5)  Lysergic acid  7300
(6)  Lysergic acid amide  7310
(7)  Methyprylon  2575
(8)  Sulfondiethylmethane  2600
(9)  Sulfonethylmethane  2605
(10)  Sulfonmethane  2610
(11)  Tiletamine and zolazepam or any salt thereof  7295Some trade or other names for a tiletamine-zolazepam combination product: TelazolSome trade or other names for tiletamine: 2-(ethylamino)-2-(2-thienyl)-cyclohexanoneSome trade or other names for zolazepam: 4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo-[3,4-e][1,4]-diazepin-7(1H)-one, flupyrazapon
(12)  Ketamine, its salts, isomers, and salts of isomers  7285Some other names for ketamine: (±)-2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone
(13)  Gamma hydroxybutyric acid, any salt, hydroxybutyric compound, derivative or preparation of gamma hydroxybutyric acid contained in a drug product for which an application has been approved under section 505 of the federal food, drug and cosmetic act
(14)  Embutramide  2020
(15)  Perampanel, its salts, isomers, and salts of isomers  2261Some other names for perampanel: 2-(2-oxo-1-phenyl-5-pyridin-2-yl-1,2 dihydropyridin-3-yl) benzonitrile

Instrument

Substances included in schedule IV

Source

https://kslegislature.gov/li/b2025_26/statute/065_000_0000_chapter/065_041_0000_article/065_041_0011_section/065_041_0011_k/

Retrieved

2026-10-31

Fingerprint

8b345b030288308a

65-4111.
 Substances included in schedule IV.

(a) The controlled substances listed in this section are included in schedule IV and the number set forth opposite each drug or substance is the DEA controlled substances code that has been assigned to it.
(b) Any material, compound, mixture or preparation that contains any quantity of the following substances including its salts, isomers and salts of isomers whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation and having a potential for abuse associated with a depressant effect on the central nervous system:
(1)  Alprazolam  2882
(2)  Barbital  2145
(3)  Brexanolone  2400
(4)  Bromazepam   2748
(5)  Camazepam  2749
(6)  Carisoprodol  8192
(7)  Chloral betaine  2460
(8)  Chloral hydrate  2465
(9)  Chlordiazepoxide  2744
(10)  Clobazam  2751
(11)  Clonazepam  2737
(12)  Clorazepate  2768
(13)  Clotiazepam  2752
(14)  Cloxazolam  2753
(15)  Daridorexant  2410
(16)  Delorazepam  2754
(17)  Diazepam  2765
(18)  Dichloralphenazone  2467
(19)  Estazolam  2756
(20)  Ethchlorvynol  2540
(21)  Ethinamate  2545
(22)  Ethyl loflazepate  2758
(23)  Fludiazepam  2759
(24)  Flunitrazepam  2763
(25)  Flurazepam  2767
(26)  Fospropofol  2138
(27)  Halazepam  2762
(28)  Haloxazolam  2771
(29)  Ketazolam  2772
(30)  Lemborexant  2245
(31)  Loprazolam  2773
(32)  Lorazepam  2885
(33)  Lormetazepam  2774
(34)  Mebutamate  2800
(35)  Medazepam  2836
(36)  Meprobamate  2820
(37)  Methohexital  2264
(38)  Methylphenobarbital (mephobarbital)  2250
(39)  Midazolam  2884
(40)  Nimetazepam  2837
(41)  Nitrazepam  2834
(42)  Nordiazepam  2838
(43)  Oxazepam  2835
(44)  Oxazolam  2839
(45)  Paraldehyde  2585
(46)  Petrichloral  2591
(47)  Phenobarbital  2285
(48)  Pinazepam  2883
(49)  Prazepam  2764
(50)  Quazepam  2881
(51)  Remimazolam  2846
(52)  Temazepam  2925
(53)  Tetrazepam  2886
(54)  Triazolam  2887
(55)  Zolpidem  2783
(56)  Zaleplon  2781
(57)  Zopiclone  2784
(58)  Alfaxalone.  2731
(59)  Suvorexant  2223
(c) Any material, compound, mixture or preparation that contains any quantity of lorcaserin (1625), including its salts, isomers and salts of such isomers, whenever the existence of such salts, isomers and salts of isomers is possible (21 U.S.C. § 812; 21 C.F.R. § 1308.14).
(d) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation that contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers (whether optical, position or geometric) and salts of such isomers whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation:
(1)  Cathine ((+)-norpseudoephedrine)  1230
(2)  Diethylpropion  1610
(3)  Fencamfamin  1760
(4)  Fenproporex  1575
(5)  Mazindol  1605
(6)  Mefenorex  1580
(7)  Pemoline (including organometalliccomplexes and chelates thereof)  1530
(8)  Phentermine  1640
The provisions of subsection (d)(8) shall expire on the date phentermine and its salts and isomers are removed from schedule IV of the federal controlled substances act (21 U.S.C. § 812; 21 C.F.R. § 1308.14).
(9)  Pipradrol  1750
(10)  Serdexmethylphenidate  1729
(11)  SPA((-)-1-dimethylamino-1, 2-diphenylethane)  1635
(12)  Sibutramine  1675
(13)  Solriamfetol (2-amino-3-phenylpropyl carbamate; benzenepropanol, beta-amino-, carbamate (ester))  1650
(14)  Mondafinil  1680
(e) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation that contains any quantity of the following, including salts thereof:
(1)  Pentazocine  9709
(2)  Butorphanol (including its optical isomers)  9720
(3)  Eluxadoline (5-[[[(2S)-2-amino-3-[4-aminocarbonyl)-2,6-dimethylphenyl]-1-oxopropyl][(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl]amino]methyl]-2-methoxybenzoic acid) (including its optical isomers) and its salts, isomers, and salts of isomers  9725
(f) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below:
(1)  Not more than 1 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit  9167
(2)  Dextropropoxyphene (alpha-(+)-4-dimethylamino-1, 2-diphenyl-3-methyl-2-propion-oxybutane)  9278
(3)  2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol, its salts, optical and geometric isomers and salts of these isomers (including tramadol)  9752
(g) Butyl nitrite and its salts, isomers, esters, ethers or their salts.
(h) The board may except by rule and regulation any compound, mixture or preparation containing any depressant substance listed in subsection (b) from the application of all or any part of this act if the compound, mixture or preparation contains one or more active medicinal ingredients not having a depressant effect on the central nervous system, and if the admixtures are included therein in combinations, quantity, proportion or concentration that vitiate the potential for abuse of the substances that have a depressant effect on the central nervous system.
History: 
L. 1972, ch. 234, § 11; L. 1974, ch. 258, § 5; L. 1978, ch. 257, § 3; L. 1979, ch. 204, § 1; L. 1982, ch. 269, § 5; L. 1985, ch. 220, § 4; L. 1986, ch. 241, § 3; L. 1989, ch. 200, § 4; L. 1990, ch. 231, § 1; L. 1991, ch. 199, § 4; L. 1993, ch. 70, § 2; L. 1996, ch. 257, § 2; L. 1998, ch. 190, § 1; L. 2000, ch. 108, § 4; L. 2001, ch. 171, § 5; L. 2011, ch. 83, § 6; L. 2012, ch. 107, § 8; L. 2014, ch. 79, § 3; L. 2015, ch. 27, § 4; L. 2016, ch. 95, § 4; L. 2017, ch. 57, § 6; L. 2022, ch. 99, § 5; L. 2024, ch. 67, § 6; July 1.